PURPOSE: Atypical teratoid rhabdoid tumors (ATRTs) arise from the central nervous system largely in the pediatric population. They portend a very poor prognosis with few long-term survivors. We describe a series of five cases at our institution. METHODS: We conducted a retrospective chart review and clinical follow-up. RESULTS: Three patients underwent chemoradiation after surgical resection; the two patients whose caretakers declined this therapy passed away soon after diagnosis. Chemoradiation included intravenous and intrathecal chemotherapy as well as intensity-modulated radiotherapy after resection. Of the patients receiving chemoradiation, two patients had infratentorial tumors, two had gross residual tumor after resection, and two were under the age of 3 years. The three patients receiving trimodality therapy remain clinically and symptomatically disease-free with follow-up times of 44, 46, and 55 months. Two of the patients have mild neuropsychiatric sequelae after therapy. CONCLUSIONS: Long-term, high-volume trials of ATRT are currently not published. We offer experience in successful long-term survival of this tumor treated with chemoradiotherapy.
PURPOSE: Atypical teratoid rhabdoid tumors (ATRTs) arise from the central nervous system largely in the pediatric population. They portend a very poor prognosis with few long-term survivors. We describe a series of five cases at our institution. METHODS: We conducted a retrospective chart review and clinical follow-up. RESULTS: Three patients underwent chemoradiation after surgical resection; the two patients whose caretakers declined this therapy passed away soon after diagnosis. Chemoradiation included intravenous and intrathecal chemotherapy as well as intensity-modulated radiotherapy after resection. Of the patients receiving chemoradiation, two patients had infratentorial tumors, two had gross residual tumor after resection, and two were under the age of 3 years. The three patients receiving trimodality therapy remain clinically and symptomatically disease-free with follow-up times of 44, 46, and 55 months. Two of the patients have mild neuropsychiatric sequelae after therapy. CONCLUSIONS: Long-term, high-volume trials of ATRT are currently not published. We offer experience in successful long-term survival of this tumor treated with chemoradiotherapy.
Authors: Adelheid Woehrer; Irene Slavc; Thomas Waldhoer; Harald Heinzl; Nadine Zielonke; Thomas Czech; Martin Benesch; Johannes A Hainfellner; Christine Haberler Journal: Cancer Date: 2010-08-24 Impact factor: 6.860
Authors: Atmaram S Pai Panandiker; Thomas E Merchant; Chris Beltran; Shengjie Wu; Shelly Sharma; Frederick A Boop; Jesse J Jenkins; Kathleen J Helton; Karen D Wright; Alberto Broniscer; Larry E Kun; Amar Gajjar Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-19 Impact factor: 7.038
Authors: Katja von Hoff; Bernward Hinkes; Elke Dannenmann-Stern; André O von Bueren; Monika Warmuth-Metz; Niels Soerensen; Angela Emser; Isabella Zwiener; Paul G Schlegel; Joachim Kuehl; Michael C Frühwald; Rolf D Kortmann; Torsten Pietsch; Stefan Rutkowski Journal: Pediatr Blood Cancer Date: 2011-07-27 Impact factor: 3.167
Authors: L Lafay-Cousin; C Hawkins; A S Carret; D Johnston; S Zelcer; B Wilson; N Jabado; K Scheinemann; D Eisenstat; C Fryer; A Fleming; C Mpofu; V Larouche; D Strother; E Bouffet; A Huang Journal: Eur J Cancer Date: 2011-10-22 Impact factor: 9.162
Authors: Tal Finkelstein-Shechter; Adam Gassas; Donald Mabbott; Annie Huang; Ute Bartels; Uri Tabori; Laura Janzen; Janzen Laura; Cynthia Hawkins; Michael Taylor; Eric Bouffet Journal: J Pediatr Hematol Oncol Date: 2010-07 Impact factor: 1.289
Authors: Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Khaled Elsayad; Jan Kriz; Laith Samhouri; Uwe Haverkamp; Ronald Straeter; Walter Stummer; Hans Theodor Eich Journal: Strahlenther Onkol Date: 2016-06-07 Impact factor: 3.621